Literature DB >> 1970184

Outcome of end-stage renal disease in patients with rare causes of renal failure. III. Systemic/vascular disorders.

A R Nissenson1, F K Port.   

Abstract

This multicentre national study has provided demographic and outcome data on over 1700 patients with rare systemic/vascular diseases as a cause of ESRD. Except for those with Henoch-Schönlein purpura, polyarteritis nodosa and Wegener's granulomatosis, women predominated. On the other hand, black patients seem less susceptible to these illnesses than white patients except for SLE. Recovery of renal function sufficient for dialysis to be discontinued was more likely in each of these diseases except for SLE than for any of the other 'rare' diseases described by us, the usual causes of renal failure as reported by the EDTA Registry or our control patients. Overall survival was quite good except in those patients with progressive systemic sclerosis whose outlook was poor.

Entities:  

Mesh:

Year:  1990        PMID: 1970184

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  5 in total

1.  Mortality and morbidity in scleroderma renal crisis: A systematic literature review.

Authors:  Hyein Kim; Frédéric Lefebvre; Sabrina Hoa; Marie Hudson
Journal:  J Scleroderma Relat Disord       Date:  2020-06-01

2.  The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.

Authors:  Wen Tang; Bhadran Bose; Stephen P McDonald; Carmel M Hawley; Sunil V Badve; Neil Boudville; Fiona G Brown; Philip A Clayton; Scott B Campbell; Chen Au Peh; David W Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-24       Impact factor: 8.237

3.  Scleroderma renal crisis: a pathology perspective.

Authors:  Ibrahim Batal; Robyn T Domsic; Thomas A Medsger; Sheldon Bastacky
Journal:  Int J Rheumatol       Date:  2010-07-28

4.  Clinical outcomes and temporal trends of immunological and non-immunological rare diseases in adult kidney transplant.

Authors:  Ester Gallo; Silvia Mingozzi; Alberto Mella; Fabrizio Fop; Roberto Presta; Manuel Burdese; Elena Boaglio; Maria Cristina Torazza; Roberta Giraudi; Gianluca Leonardi; Antonio Lavacca; Paolo Gontero; Omidreza Sedigh; Andrea Bosio; Aldo Verri; Caterina Dolla; Luigi Biancone
Journal:  BMC Nephrol       Date:  2021-11-17       Impact factor: 2.388

5.  End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.

Authors:  Wen Tang; Janaki Mohandas; Stephen P McDonald; Carmel M Hawley; Sunil V Badve; Neil Boudville; Fiona G Brown; Philip A Clayton; Kathryn J Wiggins; Kym M Bannister; Scott B Campbell; David W Johnson
Journal:  BMC Nephrol       Date:  2012-12-03       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.